Kadima, M.G.; Singh, V.; Kumar, G.; Mishra, S.; Seboletswe, P.; Ankit; Kajee, A.; Roquet-Banères, F.; Kremer, L.; Karpoormath, R.;
et al. Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents. Int. J. Mol. Sci. 2026, 27, 4385.
https://doi.org/10.3390/ijms27104385
AMA Style
Kadima MG, Singh V, Kumar G, Mishra S, Seboletswe P, Ankit, Kajee A, Roquet-Banères F, Kremer L, Karpoormath R,
et al. Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents. International Journal of Molecular Sciences. 2026; 27(10):4385.
https://doi.org/10.3390/ijms27104385
Chicago/Turabian Style
Kadima, Mukanda Gedeon, Vinayak Singh, Gobind Kumar, Sahil Mishra, Pule Seboletswe, Ankit, Afsana Kajee, Françoise Roquet-Banères, Laurent Kremer, Rajshekhar Karpoormath,
and et al. 2026. "Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents" International Journal of Molecular Sciences 27, no. 10: 4385.
https://doi.org/10.3390/ijms27104385
APA Style
Kadima, M. G., Singh, V., Kumar, G., Mishra, S., Seboletswe, P., Ankit, Kajee, A., Roquet-Banères, F., Kremer, L., Karpoormath, R., & Singh, P.
(2026). Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents. International Journal of Molecular Sciences, 27(10), 4385.
https://doi.org/10.3390/ijms27104385